Recap: Coherus BioSciences Q4 Earnings

Coherus BioSciences CHRS reported its Q4 earnings results on Thursday, February 17, 2022 at 04:01 PM.

Here's what investors need to know about the announcement.

Coherus BioSciences beat estimated earnings by 9.8%, reporting an EPS of $-0.46 versus an estimate of $-0.51.

Revenue was up $37.05 million from the same period last year.

Last quarter the company missed on EPS by $0.12, which was followed by a 6.74% increase in the share price the next day.

Here's a look at Coherus BioSciences's past performance:

Quarter	Q3 2021	Q2 2021	Q1 2021	Q4 2020
EPS Estimate	-0.22	-0.17	0.06	0.23
EPS Actual	-0.34	-0.36	0.01	0.23
Revenue Estimate	91.31M	89.81M	96.00M	115.12M
Revenue Actual	82.50M	87.64M	83.03M	110.42M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar